Telix Pharmaceuticals Sees Major Shareholder Exit
Company Announcements

Telix Pharmaceuticals Sees Major Shareholder Exit

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

State Street Global Advisors has ceased to be a substantial holder in Telix Pharmaceuticals Limited as of August 20, 2024. The details of the change, including the nature of the change and voting securities affected, were formalized through a notice that was provided to the company. This marks a significant shift in the company’s shareholder structure, which may interest investors and market watchers.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyTelix announces Cardinal Health as U.S. commercial distributor for Zircaix
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Seeks New Shares Quotation
TheFlyTelix says IPAX-1 Phase I study published in Neuro-Oncology Advances
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App